Additional 4 million doses of Valneva COVID-19 vaccine for UK

Additional 4 million doses of Valneva COVID-19 vaccine for UK

Valneva, a specialty vaccine company focused on prevention against diseases with major unmet needs, has reported that the UK Government has ordered 40 million...
Increased footfall in pharmacies: Making the most of it

Increased footfall in pharmacies: Making the most of it

Involving pharmacists in the UK’s Covid-19 vaccine roll out programme not only recognises their importance, but also presents an opportunity to reignite conversations around...
The cost of COVID-19 on lung cancer progress

The cost of COVID-19 on lung cancer progress

Lung cancer is the largest cause of cancer deaths in the world and there is no doubt that the COVID-19 pandemic has had a...
Novavax COVID-19 vaccine demonstrates 89.3% efficacy in UK trial

Novavax COVID-19 vaccine demonstrates 89.3% efficacy in UK trial

Novavax has announced that its protein-based COVID-19 vaccine candidate has an efficacy of 89.3%, following results from its Phase III clinical trial conducted in...
UK COVID-19 death rate reaches 100,000

UK COVID-19 death rate reaches 100,000

Latest figures from the Office for National Statistics (ONS) shows the total number of deaths in the UK involving COVID-19 is now more than...
Merck discontinues development of its two COVID-19 vaccines

MSD discontinues development of its COVID-19 vaccines

MSD has announced that the company is discontinuing development of its two COVID-19 vaccine candidates, V590 and V591, following a review of findings from...
COVID-19 vaccination programme ramps up with 30 new centres

COVID-19 vaccination programme ramps up with 30 new centres

More than 30 new NHS Vaccine Centres will start delivering COVID-19 jabs this week as the health service continues to accelerate the biggest immunisation...
Doctor Care Anywhere strengthens mental health support during Covid-19

Doctor Care Anywhere strengthens mental health support

One of the UK's leading providers of digital health services, Doctor Care Anywhere, is collaborating with Koa Health, a digital mental health care provider...
Moderna's COVID-19 vaccine approved by the MHRA

Moderna’s COVID-19 vaccine approved by the MHRA

Moderna’s COVID-19 vaccine has been approved for supply by the UK Medicines and Healthcare products Regulatory Agency (MHRA). This follows a thorough and rigorous assessment...
Bayer and CureVac join forces on COVID-19 vaccine candidate CVnCoV

Bayer and CureVac join forces on COVID-19 vaccine candidate

Bayer has signed a collaboration and services agreement with CureVac, in which they will support the further development, supply and key territory operations of...

Latest articles

COVID-19 one year on - key changes

COVID-19 and key changes one year on

One year on from the first confirmed case of COVID-19 in the UK, Oli Hudson, Content Director at Wilmington Healthcare, takes a look at...
FDA approval for Roche’s Actemra/RoActemra in lung disease

FDA approves Roche’s Actemra/RoActemra for interstitial lung disease

Roche has announced that the U.S. Food and Drug Administration (FDA) has approved Actemra®/RoActemra® (tocilizumab) subcutaneous injection for slowing the rate of decline in...
Pre-clinical work completed for novel COVID-19 immunotherapy

Pre-clinical work completed for novel COVID-19 immunotherapy

ISA Pharmaceuticals has announced that it has completed pre-clinical work for ISA106, a novel COVID-19 immunotherapy and is planning clinical trials. A phase 1...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
FDA approval for Roche’s Actemra/RoActemra in lung disease

FDA approves Roche’s Actemra/RoActemra for interstitial lung disease

Roche has announced that the U.S. Food and Drug Administration (FDA) has approved Actemra®/RoActemra® (tocilizumab) subcutaneous injection for slowing the rate of decline in...
NHS prescription charge to increase from 1st April

NHS prescription charge to increase from 1 April 2021

The NHS prescription charge will increase to £9.35 per prescription item from 1 April 2021 in England, according to the Pharmaceutical Services Negotiating Committee...
COVID-19 one year on - key changes

COVID-19 and key changes one year on

One year on from the first confirmed case of COVID-19 in the UK, Oli Hudson, Content Director at Wilmington Healthcare, takes a look at...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription